Fluphenazine hydrochloride 2.5 MG Oral Tablet — RxCUI 865123
RxNorm drug concept · Semantic clinical drug
RxCUI 865123
Semantic clinical drug · SCD
● Current RxNorm concept 95 FDA products
170 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI865123
Official nameFluphenazine hydrochloride 2.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluPHENAZine HCl 2.5 MG Oral Tablet
FDA products mapped95
Package NDCs mapped170
Reported Medicaid activity (SDUD)84,601 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fluphenazine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Fluphenazine is an antipsychotic medication used to manage psychotic disorders — most commonly schizophrenia. It's available as tablets, an oral liquid, and injections. The long-ac...
- Fluphenazine Decanoate Injection is chemically designed to release slowly after a single shot, so one injection can keep working for up to four weeks or even longer. The regular ta...
- How is the long-acting injection different from the tablets or regular shot?
- The most common side effects involve movement — things like muscle stiffness, a restless, fidgety feeling, or tremors. These can often be managed by adjusting your dose or adding a...
🕸️ Concept Web — How Fluphenazine hydrochloride 2.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fluphenazine hydrochloride 2.5 MG Oral Tablet
RxCUI 865123 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Fluphenazine
4496IN -
Fluphenazine hydrochloride
203207PIN
-
Fluphenazine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fluphenazine Oral Tablet
372240SCDF -
Fluphenazine hydrochloride Oral Tablet
2647497SCDFP -
Fluphenazine Oral Product
1161443SCDG -
Fluphenazine Pill
1161444SCDG -
Fluphenazine hydrochloride Oral Product
2663299SCDGP -
Fluphenazine hydrochloride Pill
2661661SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Fluphenazine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fluphenazine hydrochloride 2.5 MG
865122SCDC
-
Fluphenazine hydrochloride 2.5 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fluphenazine hydrochloride 2.5 MG
SCDC · 865122 -
Fluphenazine Oral Tablet
SCDF · 372240 -
Fluphenazine hydrochloride Oral Tablet
SCDFP · 2647497 -
Fluphenazine Oral Product
SCDG · 1161443 -
Fluphenazine Pill
SCDG · 1161444 -
Fluphenazine hydrochloride Oral Product
SCDGP · 2663299 -
Fluphenazine hydrochloride Pill
SCDGP · 2661661
📦 FDA Products & Package NDCs
95 products · 170 package NDCs
170 package NDCs map to RxCUI 865123 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71205-0840-11 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-840-11) | Fluphenazine Hydrochloride | Proficient Rx LP | 2023-02-21 |
| 71205-0840-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-840-30) | Fluphenazine Hydrochloride | Proficient Rx LP | 2023-02-21 |
| 71205-0840-55 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-840-55) | Fluphenazine Hydrochloride | Proficient Rx LP | 2023-02-21 |
| 71205-0840-60 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-840-60) | Fluphenazine Hydrochloride | Proficient Rx LP | 2023-02-21 |
| 71205-0840-64 | 240 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-840-64) | Fluphenazine Hydrochloride | Proficient Rx LP | 2023-02-21 |
| 71205-0840-72 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-840-72) | Fluphenazine Hydrochloride | Proficient Rx LP | 2023-02-21 |
| 71205-0840-78 | 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-840-78) | Fluphenazine Hydrochloride | Proficient Rx LP | 2023-02-21 |
| 71205-0840-90 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71205-840-90) | Fluphenazine Hydrochloride | Proficient Rx LP | 2023-02-21 |
| 72205-0112-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-112-05) | Fluphenazine Hydrochloride | Novadoz Pharmaceuticals LLC | 2023-09-14 |
| 72205-0112-91 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-112-91) | Fluphenazine Hydrochloride | Novadoz Pharmaceuticals LLC | 2023-09-14 |
| 72205-0113-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-113-05) | Fluphenazine Hydrochloride | Novadoz Pharmaceuticals LLC | 2023-09-14 |
| 72205-0113-91 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-113-91) | Fluphenazine Hydrochloride | Novadoz Pharmaceuticals LLC | 2023-09-14 |
| 72205-0114-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-114-05) | Fluphenazine Hydrochloride | Novadoz Pharmaceuticals LLC | 2023-09-14 |
| 72205-0114-91 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-114-91) | Fluphenazine Hydrochloride | Novadoz Pharmaceuticals LLC | 2023-09-14 |
| 72205-0115-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-115-05) | Fluphenazine Hydrochloride | Novadoz Pharmaceuticals LLC | 2023-09-14 |
| 72205-0115-91 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-115-91) | Fluphenazine Hydrochloride | Novadoz Pharmaceuticals LLC | 2023-09-14 |
| 90096-0121-01 | 100 TABLET, FILM COATED in 1 BOTTLE (90096-121-01) | Fluphenazine Hydrochloride | Zameer Pharmaceuticals LLC | 2022-01-01 |
| 90096-0122-01 | 100 TABLET, FILM COATED in 1 BOTTLE (90096-122-01) | Fluphenazine Hydrochloride | Zameer Pharmaceuticals LLC | 2022-01-01 |
| 90096-0123-01 | 100 TABLET, FILM COATED in 1 BOTTLE (90096-123-01) | Fluphenazine Hydrochloride | Zameer Pharmaceuticals LLC | 2022-01-01 |
| 90096-0124-01 | 100 TABLET, FILM COATED in 1 BOTTLE (90096-124-01) | Fluphenazine Hydrochloride | Zameer Pharmaceuticals LLC | 2022-01-01 |
Observed labelers:
Proficient Rx LP (36) ·
Glenmark Pharmaceuticals Inc., USA (12) ·
Alembic Pharmaceuticals Inc. (8) ·
Alembic Pharmaceuticals Limited (8) ·
Camber Pharmaceuticals, Inc. (8) ·
Lannett Company, Inc. (8)
· +18 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.